<html>

<head>
<meta http-equiv="Content-Language" content="nl-be">
<meta http-equiv="Content-Type" content="text/html; charset=windows-1252">
<title>Acute myeloïde leukemie met karakteristieke cytogenetische afwijkingen</title>
</head>

<body link="#405890" vlink="#405890" alink="#405890" text="#405890" background="../../../images/algemeen/bgcenter.gif" style="background-attachment: fixed">

<p>&nbsp;</p>
<table border="0" width="100%" cellspacing="0" cellpadding="10" style="padding-bottom: 0; background-attachment: fixed">
	<tr>
		<td colspan="5" valign="top">
        <!--webbot bot="Include" U-Include="../../../gemeenschappelijk/hoofding_pagina.htm" TAG="BODY" startspan -->

<table border="0" width="100%" cellspacing="0" cellpadding="0">
  <tr>
    <th width="100%">
      <p align="left"><font size="2" color="#405890" face="Times New Roman">
      <a target="_blank" href="../../../index.htm">HEMATOLOGIE
      ATLAS</a>&nbsp;&nbsp;&nbsp;&nbsp;<a target="_blank" href="file://Ntserver7/laboratoriumgeneeskunde/Web_Server/HB/SOP/SOP/SOP_092_cytologie/index/index.htm">SOP-092-Cytologie
      BM-PB-BC</a>&nbsp;&nbsp;&nbsp;&nbsp;<a href="file://Ntserver7/laboratoriumgeneeskunde/Web_Server/HB/SOP/SOP/SOP_095_cytologie_vochten/index/index.htm">SOP-095-Cytologie vochten</a>&nbsp;&nbsp;&nbsp;
      <a href="file://Ntserver7/laboratoriumgeneeskunde/Web_Server/HB/SOP/SOP/SOP_091_cytochemie/index/index.htm">SOP-091-Cytochemische kleuringen BM-PB-BC</a></font></th>
  </tr>
</table>

<!--webbot bot="Include" i-checksum="16758" endspan --></td>
	</tr>
	<tr>
		<td colspan="5" valign="top"><font face="Times New Roman" size="4"><b>Acute myeloïde leukemie met 
		karakteristieke cytogenetische afwijkingen</b></font></td>
	</tr>
	<tr>
		<td colspan="5" valign="top">
			<p><a name="aml1"></a></p>
			<hr size="1" color="#405890"></td>
	</tr>
	<tr>
		<td valign="top" colspan="5">
			<p align="left"><b>
        <span style="font-family: Times New Roman">Acute myeloïde leukemie met 
            t(8;21)(q22;q22);(AML1/ETO</span></b><span style="font-family: Times New Roman">)</span></td>
	</tr>
	<tr>
		<td valign="top">
			<p style="margin-top: 0; margin-bottom: 0">
			<font size="2" face="Times New Roman">beschrijving</font></td>
		<td valign="top" colspan="4">
        <p style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- voornamelijk granulocytaire 
        uitrijping</font></p>
        <p style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- FAB: vaak overeenkomend met AML 
        M2</font></p>
        <p style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- 5 - 12% van AML - patiënten</font></p>
        <p style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- voornamelijk op relatief jonge 
        leeftijd</font></p></td>
	</tr>
	<tr>
		<td valign="top">
		<p style="margin-top: 0; margin-bottom: 0"><font size="2" face="Times New Roman">
		kliniek</font></td>
		<td valign="top" colspan="4">
        <p style="margin-top: 0; margin-bottom: 0">
        <span style="font-family: Times New Roman"><font size="2">- cfr. kliniek AML</font></span></p>
        <p style="margin-top: 0; margin-bottom: 0">
        <span style="font-family: Times New Roman"><font size="2">- soms 
        geassocieerd met myeloïd sarcoma</font></span></td>
	</tr>
	<tr>
		<td valign="top">
		<p style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">cytologie</font></td>
		<td valign="top" colspan="4">
		<p style="margin-top: 0; margin-bottom: 0">
		<font size="2" face="Times New Roman">- </font><span lang="NL-BE" style="font-family: Times New Roman"><font size="2">
        anemie, 
        trombocytopenie, leukocytose (vaak talrijke blasten)</font></span></p>
        <p style="margin-top: 0; margin-bottom: 0">
		<span style="font-family: Times New Roman"><font size="2">- </font>
        </span><font face="Times New Roman" size="2"><span lang="NL-BE">blasten 
        tonen vaak Auerstaven en azurofiele granulen (soms erg grote: pseudo 
        Chediak-Higashi)</span></font></p>
        <p style="margin-top: 0; margin-bottom: 0">
		<font face="Times New Roman"><font size="2">-</font><span lang="NL-BE"><font size="2"> 
        indien blasten &lt; 20% toch nog AML</font></span></font></p>
        <p style="margin-top: 0; margin-bottom: 0">
		<span style="font-style: normal; font-variant: normal; font-weight: normal; font-family: Times New Roman" lang="NL-BE">
        <font size="2">-&nbsp;</font></span><span lang="NL-BE"><font face="Times New Roman" size="2">variabele graad van myelodysplasie 
        is mogelijk ovv. abnormale nucleaire segmentatie (bv. pseudo Pelger-Huet) 
        en&nbsp; afwijkende cytoplasmatische kleuring (uniform rozige kleur)</font></span></p>
        <p style="margin-top: 0; margin-bottom: 0">
		<font face="Times New Roman" size="2">-<span lang="NL-BE"> vaak </span>&#8593;<span lang="NL-BE"> 
        eosinofielen&nbsp; in PB/BM</span></font></p>
        <p style="margin-top: 0; margin-bottom: 0">
		<font face="Times New Roman" size="2"><span lang="NL-BE">- monocytaire 
        component vaak </span>&#8595;<span lang="NL-BE"> /afwezig</span></font></p>
        <p style="margin-top: 0; margin-bottom: 0">
		<font face="Times New Roman" size="2"><span lang="NL-BE">- nl. voorkomen 
        van erytroblasten en megakaryocyten</span></font></p>
		</td>
	</tr>
	<tr>
		<td valign="top">
		<p style="margin-top: 0; margin-bottom: 0"><font size="2" face="Times New Roman">
		andere</font></td>
		<td valign="top" colspan="4">
		<p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="NL-BE"><font size="2" face="Times New Roman">1. Immunofenotypering </font></span></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman">
        <font size="2">&nbsp;</font><span lang="NL-BE"><font size="2"> - positief voor 
        myeloïde 
        merkers (CD13, CD33, MPO); vaak CD34</font></span></font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="NL-BE"><font size="2" face="Times New Roman"> &nbsp; - vaak co-expressie van B-cel 
        geassocieerde merker (CD19) en CD56</font></span></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="NL-BE"><font size="2" face="Times New Roman">2. Cytogenetica / moleculaire diagnostiek</font></span></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="FR"><font size="2" face="Times New Roman">&nbsp; - t(8;21)(q22;q22); 
        (AML1/ETO-fusiegen)</font></span></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="NL-BE"><font size="2" face="Times New Roman">3. Prognose</font></span></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman">
        <font size="2">&nbsp; - hoge</font><span lang="NL-BE"><font size="2"> 
        kans op complete remissie (CR)</font></span></font></td>
	</tr>
	<tr>
		<td valign="top">
		<font size="2">informatie 1</font></td>
		<td valign="top" colspan="4">
		<p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <b>
        <span lang="NL-BE"><font size="2" face="Times New Roman">BM-06-648 </font></span>
        </b></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- vrouw, 39 jaar</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- kliniek: persisterende hoest 
        sedert 14 dagen, ecchymosen, anemie (moe, palpitaties, dyspnee, 
        hoofdpijn)</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- Hb 9.9 g/dl; WBC 15.7 10x9/l; 
        Blpl 54000</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="NL-BE"><font size="2" face="Times New Roman">- morfologie: 
        AML M2 (FAB) en AML met t(8;21) (WHO) met 36.7% blasten in beenmerg</font></span></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="fr"><font face="Times New Roman" size="2">- IF (blasten): 
        CD34+, CD117+, CD13+, CD33+, MPO+, <b>CD19+</b>, HLA-Dr+, CD15+</font></span></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="fr"><font face="Times New Roman" size="2">- cytogenetica:
        </font></span><span lang="FR"><font size="2" face="Times New Roman">t(8;21)(q22;q22); 
        (AML1/ETO-fusiegen)</font></span></p>
        </td>
	</tr>
    <tr>
		<td valign="top" width="13%">
		<p style="margin-top: 0; margin-bottom: 0"><font size="2" face="Times New Roman">
		illustratie</font></td>
		<td valign="top" colspan="4">
		&nbsp;</td>
	</tr>
    <tr>
		<td valign="top" colspan="5"><font size="2">&nbsp; <u>perifeer bloed</u></font></td>
	</tr>
    <tr>
		<td valign="top">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_648_1.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_648_1_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_648_1.jpg"></a></td>
		<td valign="top" width="22%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_648_2.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_648_2_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_648_2.jpg"></a></td>
		<td valign="top" width="21%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_648_3.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_648_3_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_648_3.jpg"></a></td>
		<td valign="top" width="20%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_648_4.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_648_4_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_648_4.jpg"></a></td>
		<td valign="top" width="21%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_648_5.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_648_5_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_648_5.jpg"></a></td>
	</tr>
    <tr>
		<td valign="top" colspan="5">&nbsp; <u><font size="2">beenmerg</font></u></td>
	</tr>
    <tr>
		<td valign="top">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_648_1.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_648_1_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_648_1.jpg"></a></td>
		<td valign="top" width="22%">
		<p style="margin-top: 0; margin-bottom: 0">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_648_2.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_648_2_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_648_2.jpg"></a></td>
		<td valign="top" width="21%">
		<p style="margin-top: 0; margin-bottom: 0">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_648_3.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_648_3_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_648_3.jpg"></a></td>
		<td valign="top" width="20%">
		<p style="margin-top: 0; margin-bottom: 0">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_648_4.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_648_4_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_648_4.jpg"></a></td>
		<td valign="top" width="21%">
		<p style="margin-top: 0; margin-bottom: 0">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_648_5.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_648_5_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_648_5.jpg"></a></td>
	</tr>
    <tr>
		<td valign="top">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_648_6.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_648_6_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_648_6.jpg"></a></td>
		<td valign="top" width="22%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_648_7.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_648_7_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_648_7.jpg"></a></td>
		<td valign="top" width="21%">
		&nbsp;</td>
		<td valign="top" width="20%">
		&nbsp;</td>
		<td valign="top" width="21%">
		&nbsp;</td>
	</tr>
    <tr>
		<td valign="top">
		<font size="2">informatie 2</font></td>
		<td valign="top" colspan="4">
		&nbsp;</td>
	</tr>
    <tr>
		<td valign="top" width="14%">
		<p style="margin-top: 0; margin-bottom: 0"><font size="2" face="Times New Roman">
		illustratie</font></td>
		<td valign="top" colspan="4">
		&nbsp;</td>
	</tr>
	<tr>
		<td valign="top" colspan="5"><font size="2">&nbsp; <u>perifeer bloed</u></font></td>
		</tr>
	<tr>
		<td valign="top">&nbsp;</td>
		<td valign="top">
		&nbsp;</td>
		<td valign="top">
		&nbsp;</td>
		<td valign="top">
		&nbsp;</td>
		<td valign="top">
		&nbsp;</td>
	</tr>
	<tr>
		<td valign="top" colspan="5"><font size="2">&nbsp; <u>beenmerg</u></font></td>
		</tr>
	<tr>
		<td valign="top">&nbsp;</td>
		<td valign="top">
		&nbsp;</td>
		<td valign="top">
		&nbsp;</td>
		<td valign="top">
		&nbsp;</td>
		<td valign="top">
		&nbsp;</td>
	</tr>
	<tr>
		<td valign="top" colspan="5"><font size="2">&nbsp; <u>andere kleuringen</u></font></td>
		</tr>
	<tr>
		<td valign="top">&nbsp;</td>
		<td valign="top">
		<p style="margin-top: 0; margin-bottom: 0">&nbsp;</td>
		<td valign="top">
		<p style="margin-top: 0; margin-bottom: 0">&nbsp;</td>
		<td valign="top">
		<p style="margin-top: 0; margin-bottom: 0">&nbsp;</td>
		<td valign="top">
		<p style="margin-top: 0; margin-bottom: 0">&nbsp;</td>
	</tr>
	<tr>
		<td valign="top" colspan="5">
		<p align="center">
		<font face="Times New Roman">
		<b>
		<a target="_self" href="acute_myeloide_leukemie.htm">terug</a></b></font></td>
	</tr>
	<tr>
		<td valign="top" colspan="5">
		<p><font face="Times New Roman"><a name="aml2"></a></font></p>
		<hr size="1" color="#405890"></td>
	</tr>
	<tr>
		<td valign="top" colspan="5">
		<p align="left">
		<b>
        <span style="font-family: Times New Roman">Acute myeloïde leukemie</span><span lang="NL-BE" style="font-size: 12.0pt; font-family: Times New Roman"> 
        met inv(16)(p13 of t(16;16);(CBF&#946;/MYH11)</span></b></td>
	</tr>
	<tr>
		<td valign="top">
		<p style="margin-top: 0; margin-bottom: 0">
			<font size="2" face="Times New Roman">beschrijving</font></td>
		<td valign="top" colspan="4">
		<p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="NL-BE"><font size="2" face="Times New Roman">- gekenmerkt 
        door een monocytaire en granulocytaire uitrijping, karakteristiek 
        aanwezigheid van een afwijkende eosinofiele populatie in BM</font></span></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="NL-BE"><font size="2" face="Times New Roman">- FAB: AMML Eo</font></span></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="NL-BE"><font size="2" face="Times New Roman">- 10 - 12% van AML - patiënten</font></span></p>
        <p style="margin-top: 0; margin-bottom: 0">
        <span>
        <font size="2" face="Times New Roman">-
        kan voorkomen in alle leeftijdscategorieën, voornamelijk bij jongere 
        patiënten</font></span></td>
	</tr>
	<tr>
		<td valign="top">
		<p style="margin-top: 0; margin-bottom: 0"><font size="2" face="Times New Roman">
		kliniek</font></td>
		<td valign="top" colspan="4">
		<p style="margin-top: 0; margin-bottom: 0"><span lang="NL-BE">
        <font size="2" face="Times New Roman">- cfr. kliniek AML</font></span></p>
        <p style="margin-top: 0; margin-bottom: 0"><span lang="NL-BE">
        <font size="2" face="Times New Roman">- myeloïde sarcomen kunnen voorkomen</font></span></td>
	</tr>
	<tr>
		<td valign="top">
		<p style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">cytologie</font></td>
		<td valign="top" colspan="4">
		<p style="margin-top: 0; margin-bottom: 0"><font face="Times New Roman">
        <span lang="NL-BE"><font size="2">-</font></span><font size="2"><span lang="NL-BE"> 
        anemie, trombocytopenie, vaak leukocytose</span></font></font></p>
        <p style="margin-top: 0; margin-bottom: 0"><span lang="NL-BE">
        <font size="2" face="Times New Roman">- morfologische kenmerken van 
        acute myelo-monocytaire leukemie (cfr.AMML)</font></span></p>
        <p style="margin-top: 0; margin-bottom: 0"><span lang="NL-BE">
        <font size="2" face="Times New Roman">- indien blasten &lt; 20% toch AML</font></span></p>
        <p style="margin-top: 0; margin-bottom: 0"><span lang="NL-BE">
        <font size="2" face="Times New Roman">- aberrante eosinofielen in BM, 
        typisch met grote korrels (purper - violet, soms &lt; 5%) met soms voorkomen 
        van nucleaire hyposegmentatie</font></span></p>
        <p style="margin-top: 0; margin-bottom: 0">
        <span lang="NL-BE" style="font-family: Times New Roman"><font size="2">- 
        vaak relatief laag aantal neutrofielen in BM</font></span></td>
	</tr>
	<tr>
		<td valign="top">
		<p style="margin-top: 0; margin-bottom: 0"><font size="2" face="Times New Roman">
		andere</font></td>
		<td valign="top" colspan="4">
		<p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="NL-BE"><font size="2" face="Times New Roman">1. Immunofenotypering</font></span></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="NL-BE"><font size="2" face="Times New Roman">&nbsp; - positief voor myeloïde 
        merkers (CD13,CD33,MPO) met vaak co-expressie CD2 , monocytaire merkers 
        (CD 14, CD11b/c, CD14, CD36,CD4,CD36)</font></span></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="NL-BE"><font size="2" face="Times New Roman">2. Cytogenetica / moleculaire 
        diagnostiek</font></span></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="NL-BE"><font size="2" face="Times New Roman">&nbsp; - inv(16) of t(16;16);(CBF&#946;/MYH11-fusiegen)</font></span></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="NL-BE"><font size="2" face="Times New Roman">3. Prognose</font></span></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="NL-BE"><font size="2" face="Times New Roman">&nbsp; - relatief goede prognose</font></span></td>
	</tr>
	<tr>
		<td valign="top">
		<font size="2">informatie 1</font></td>
		<td valign="top" colspan="4">
		<p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <b>
        <span lang="NL-BE"><font size="2" face="Times New Roman">BM-05-678 </font></span>
        </b></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- vrouw, 32 jaar</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- kliniek: nausea, braken, 
        abdominale krampen en anorexie sedert 3 weken</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- Hb 6.5 g/dl; WBC 86.7 10x9/l; 
        Blpl 29000</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="NL-BE"><font size="2" face="Times New Roman">- morfologie: 
        AML M4Eo (FAB) en AML met inv(16) (WHO) met 43.8% blasten in beenmerg en 
        aberrante eosinofielen!</font></span></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="fr"><font face="Times New Roman" size="2">- IF (blasten): 
        CD34+, CD117+, CD13+, CD33+, MPO+, HLA-Dr+, CD15+, CD4+ en rijpere 
        monocytaire populatie (positief voor CD13, CD33, CD4, CD11b, CD14, CD15, 
        HLA-Dr; negatief voor CD34 en CD117)</font></span></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="fr"><font face="Times New Roman" size="2">- cytogenetica:
        </font></span>
        <span lang="NL-BE"><font size="2" face="Times New Roman">inv(16) of t(16;16);(CBF&#946;/MYH11-fusiegen)</font></span></p>
        </td>
	</tr>
    <tr>
		<td valign="top" width="13%">
		<p style="margin-top: 0; margin-bottom: 0"><font size="2" face="Times New Roman">
		illustratie</font></td>
		<td valign="top" colspan="4">
		&nbsp;</td>
	</tr>
    <tr>
		<td valign="top" colspan="5"><font size="2">&nbsp; <u>perifeer bloed</u></font></td>
	</tr>
    <tr>
		<td valign="top">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_678_1.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_678_1_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_678_1.jpg"></a></td>
		<td valign="top" width="22%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_678_2.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_678_2_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_678_2.jpg"></a></td>
		<td valign="top" width="21%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_678_3.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_678_3_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_678_3.jpg"></a></td>
		<td valign="top" width="20%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_678_4.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_678_4_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_678_4.jpg"></a></td>
		<td valign="top" width="21%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_678_5.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_678_5_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_678_5.jpg"></a></td>
	</tr>
    <tr>
		<td valign="top" colspan="5"><font size="2">&nbsp; <u>beenmerg</u></font></td>
	</tr>
    <tr>
		<td valign="top">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_678_1.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_678_1_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_678_1.jpg"></a></td>
		<td valign="top" width="22%">
		<p style="margin-top: 0; margin-bottom: 0">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_678_2.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_678_2_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_678_2.jpg"></a></td>
		<td valign="top" width="21%">
		<p style="margin-top: 0; margin-bottom: 0">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_678_3.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_678_3_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_678_3.jpg"></a></td>
		<td valign="top" width="20%">
		<p style="margin-top: 0; margin-bottom: 0">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_678_4.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_678_4_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_678_4.jpg"></a></td>
		<td valign="top" width="21%">
		<p style="margin-top: 0; margin-bottom: 0">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_678_5.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_678_5_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_678_5.jpg"></a></td>
	</tr>
    <tr>
		<td valign="top">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_678_6.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_678_6_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_678_6.jpg"></a></td>
		<td valign="top" width="22%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_678_7.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_678_7_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_678_7.jpg"></a></td>
		<td valign="top" width="21%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_678_8.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_678_8_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_678_8.jpg"></a></td>
		<td valign="top" width="20%">
		&nbsp;</td>
		<td valign="top" width="21%">
		&nbsp;</td>
	</tr>
    <tr>
		<td valign="top">
		<font size="2">informatie 2</font></td>
		<td valign="top" colspan="4">
		<p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <b>
        <span lang="NL-BE"><font size="2" face="Times New Roman">BM-05-1584 </font></span>
        </b></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- man, 50 jaar</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- kliniek: vermoeidheid, 
        inspanningsdyspnoe, bleek sedert 4 weken</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- Hb 8.9 g/dl; WBC 9.9 10x9/l; 
        Blpl 33000</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="NL-BE"><font size="2" face="Times New Roman">- morfologie: 
        AML M2Eo (FAB) en AML met inv(16) (WHO) met 36.7% blasten in beenmerg en 
        aberrante eosinofielen!</font></span></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="fr"><font face="Times New Roman" size="2">- IF (blasten): 
        CD34+, CD117+, CD13+, CD33+, MPO+, HLA-Dr+, CD56+</font></span></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="fr"><font face="Times New Roman" size="2">- botboor: acute 
        myelo-monocytoïde leukemie met opvallende eosinofilie</font></span></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="fr"><font face="Times New Roman" size="2">- cytogenetica:
        </font></span>
        <span lang="NL-BE"><font size="2" face="Times New Roman">inv(16) of t(16;16);(CBF&#946;/MYH11-fusiegen)</font></span></p>
        </td>
	</tr>
    <tr>
		<td valign="top" width="13%">
		<p style="margin-top: 0; margin-bottom: 0"><font size="2" face="Times New Roman">
		illustratie</font></td>
		<td valign="top" colspan="4">
		&nbsp;</td>
	</tr>
    <tr>
		<td valign="top" colspan="5"><font size="2">&nbsp; <u>perifeer bloed</u></font></td>
	</tr>
    <tr>
		<td valign="top">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_1584_1.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_1584_1_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_1584_1.jpg"></a></td>
		<td valign="top" width="22%">
		&nbsp;</td>
		<td valign="top" width="21%">
		&nbsp;</td>
		<td valign="top" width="20%">
		&nbsp;</td>
		<td valign="top" width="21%">
		&nbsp;</td>
	</tr>
    <tr>
		<td valign="top" colspan="5"><font size="2">&nbsp; <u>beenmerg</u></font></td>
	</tr>
	<tr>
		<td valign="top">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1584_1.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1584_1_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1584_1.jpg"></a></td>
		<td valign="top" width="22%">
		<p style="margin-top: 0; margin-bottom: 0">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1584_2.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1584_2_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1584_2.jpg"></a></td>
		<td valign="top" width="21%">
		<p style="margin-top: 0; margin-bottom: 0">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1584_3.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1584_3_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1584_3.jpg"></a></td>
		<td valign="top" width="20%">
		<p style="margin-top: 0; margin-bottom: 0">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1584_4.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1584_4_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1584_4.jpg"></a></td>
		<td valign="top" width="21%">
		<p style="margin-top: 0; margin-bottom: 0">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1584_5.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1584_5_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1584_5.jpg"></a></td>
	</tr>
    <tr>
		<td valign="top">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1584_6.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1584_6_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1584_6.jpg"></a></td>
		<td valign="top" width="22%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1584_7.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1584_7_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1584_7.jpg"></a></td>
		<td valign="top" width="21%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1584_8.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1584_8_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1584_8.jpg"></a></td>
		<td valign="top" width="20%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1584_9.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1584_9_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1584_9.jpg"></a></td>
		<td valign="top" width="21%">
		&nbsp;</td>
	</tr>
	<tr>
		<td valign="top" colspan="5">
		<p align="center">
		<font face="Times New Roman">
		<b>
		<a target="_self" href="acute_myeloide_leukemie.htm">terug</a></b></font></td>
	</tr>
	<tr>
		<td valign="top" colspan="5">
		<p><font face="Times New Roman"><a name="aml3"></a></font></p>
		<hr color="#405890" size="1">
        </td>
	</tr>
	<tr>
		<td valign="top" colspan="5">
		<p style="margin-top: 0; margin-bottom: 0">
        <span style="font-size: 12.0pt; font-family: Times New Roman; font-weight: 700">
        Acute promyelocytaire leukemie (AML met&nbsp; t(15;17)(q22;q12);(PML/RARa) en 
        varianten)</span></td>
	</tr>
	<tr>
		<td valign="top">
		<p style="margin-top: 0; margin-bottom: 0">
			<font size="2" face="Times New Roman">beschrijving</font></td>
		<td valign="top" colspan="4">
		<p style="margin-top: 0; margin-bottom: 0"><span lang="NL-BE">
        <font size="2" face="Times New Roman">- predominantie van promyelocyten</font></span></p>
        <p style="margin-top: 0; margin-bottom: 0"><span lang="NL-BE">
        <font size="2" face="Times New Roman">- FAB:AML M3</font></span></p>
        <p style="margin-top: 0; margin-bottom: 0"><span lang="NL-BE">
        <font size="2" face="Times New Roman">- 8 - 5% van AML - patiënten</font></span></td>
	</tr>
	<tr>
		<td valign="top">
		<p style="margin-top: 0; margin-bottom: 0"><font size="2" face="Times New Roman">
		kliniek</font></td>
		<td valign="top" colspan="4">
		<p style="margin-top: 0; margin-bottom: 0"><span lang="NL-BE">
        <font size="2" face="Times New Roman">- cfr. kliniek AML</font></span></p>
        <p style="margin-top: 0; margin-bottom: 0"><span lang="NL-BE">
        <font size="2" face="Times New Roman">-&nbsp; vaak voorkomen van 
        gedissemineerde intravasculaire coagulatie (DIC)</font></span></td>
	</tr>
	<tr>
		<td valign="top">
		<p style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">cytologie</font></td>
		<td valign="top" colspan="4">
		<p style="margin-top: 0; margin-bottom: 0"><span lang="NL-BE">
        <font size="2" face="Times New Roman">- vaak pancytopenie bij 
        hypergranulaire vorm; frequent leukocytose in hypogranulaire vorm</font></span></p>
        <p style="margin-top: 0; margin-bottom: 0"><span lang="NL-BE">
        <font size="2" face="Times New Roman">- predominantie van aberrante 
        promyelocyten (APL) in BM met vaak niervormige/bilobaire kern</font></span></p>
        <p style="margin-top: 0; margin-bottom: 0"><span lang="NL-BE">
        <font size="2" face="Times New Roman">- hypergranulaire en hypo (micro) 
        granulaire vorm</font></span></p>
        <p style="margin-top: 0; margin-bottom: 0">
        <font size="2" face="Times New Roman"><span lang="NL-BE">&nbsp;&nbsp; a) </span></font><font face="Times New Roman"><span lang="NL-BE" style="font-size: 12.0pt"><span style="font-style: normal; font-variant: normal; font-weight: normal"><font size="2">h</font></span><font size="2">ypergranulaire 
        vorm: intense azurofiele granulatie (soms giant korrels); 
        karakteristieke cellen met&nbsp; takkenbossen Auerstaven (faggot cells)</font></span></font></p>
        <p style="margin-top: 0; margin-bottom: 0">
        <font size="2" face="Times New Roman"><span lang="NL-BE">&nbsp;&nbsp; b)</span></font><span style="font-style: normal; font-variant: normal; font-weight: normal; font-family: Times New Roman" lang="NL-BE"><font size="2">&nbsp;</font></span><span lang="NL-BE" style="font-size: 12.0pt"><font size="2" face="Times New Roman">hypogranulaire 
        vorm: afwezige of zwakke fijne korreling; typisch bilobaire kern; weinig 
        cellen met Auerstaven</font></span></p>
        <p style="margin-top: 0; margin-bottom: 0">
        <span lang="NL-BE" style="font-family: Times New Roman"><font size="2">- 
        sterk positieve MPO-reactie</font></span></td>
	</tr>
	<tr>
		<td valign="top">
		<p style="margin-top: 0; margin-bottom: 0"><font size="2" face="Times New Roman">
		andere</font></td>
		<td valign="top" colspan="4">
		<p style="margin-top: 0; margin-bottom: 0"><span lang="NL-BE">
        <font size="2" face="Times New Roman">1. Immunofenotypering</font></span></p>
        <p style="margin-top: 0; margin-bottom: 0"><span lang="NL-BE">
        <font size="2" face="Times New Roman">&nbsp; - vaak positief voor CD13, CD33</font></span></p>
        <p style="margin-top: 0; margin-bottom: 0"><span lang="NL-BE">
        <font size="2" face="Times New Roman">&nbsp; - vaak negatief voor HLA-DR en CD34, CD15</font></span></p>
        <p style="margin-top: 0; margin-bottom: 0"><span lang="NL-BE">
        <font size="2" face="Times New Roman">&nbsp; - frequent co-expressie van CD2 en CD9</font></span></p>
        <p style="margin-top: 0; margin-bottom: 0"><span lang="NL-BE">
        <font size="2" face="Times New Roman">2. Cytogenetica / moleculaire diagnostiek</font></span></p>
        <p style="margin-top: 0; margin-bottom: 0">
        <font size="2" face="Times New Roman">&nbsp; - 
        t(15;17)(q22;q12);(PML/RARa-fusiegen)</font></p>
        <p style="margin-top: 0; margin-bottom: 0"><font face="Times New Roman"><font size="2">3. </font>
        <span lang="NL-BE"><font size="2">Prognose</font></span></font></p>
        <p style="margin-top: 0; margin-bottom: 0"><font face="Times New Roman"><font size="2">&nbsp; - </font>
        <span lang="NL-BE"><font size="2">relatief 
        goede prognose</font></span></font></td>
	</tr>
	<tr>
		<td valign="top">
		<font size="2">informatie 1</font></td>
		<td valign="top" colspan="4">
		<p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <b>
        <span lang="NL-BE"><font size="2" face="Times New Roman">BM-06-332 </font></span>
        </b></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- vrouw, 34 jaar</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- kliniek: ecchymosen, menorraghie, 
        neus- en tandvleesbloedingen sedert 2 weken</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- Hb 9.4 g/dl; WBC 1.5 10x9/l; 
        Blpl 119000</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="NL-BE"><font size="2" face="Times New Roman">- morfologie: 
        AML M3 (FAB) en AML met t(15;17) (WHO) met 78% blasten in beenmerg</font></span></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="fr"><font face="Times New Roman" size="2">- IF (blasten): 
        CD34+, CD117+, CD13+, CD33+, MPO+, CD15+, CD4 (zwak/partieel), CD56+</font></span></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="fr"><font face="Times New Roman" size="2">- cytogenetica:
        </font></span>
        <font size="2" face="Times New Roman">t(15;17)(q22;q12);(PML/RARa-fusiegen)</font></p>
        </td>
	</tr>
    <tr>
		<td valign="top" width="13%">
		<p style="margin-top: 0; margin-bottom: 0"><font size="2" face="Times New Roman">
		illustratie</font></td>
		<td valign="top" colspan="4">
		&nbsp;</td>
	</tr>
    <tr>
		<td valign="top" colspan="5"><font size="2">&nbsp; <u>perifeer bloed</u></font></td>
	</tr>
    <tr>
		<td valign="top">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_332_1.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_332_1_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_332_1.jpg"></a></td>
		<td valign="top" width="22%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_332_2.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_332_2_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_332_2.jpg"></a></td>
		<td valign="top" width="21%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_332_3.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_332_3_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_332_3.jpg"></a></td>
		<td valign="top" width="20%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_332_4.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_332_4_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_332_4.jpg"></a></td>
		<td valign="top" width="21%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_332_5.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_332_5_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_332_5.jpg"></a></td>
	</tr>
    <tr>
		<td valign="top">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_332_6.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_332_6_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_332_6.jpg"></a></td>
		<td valign="top" width="22%">
		&nbsp;</td>
		<td valign="top" width="21%">
		&nbsp;</td>
		<td valign="top" width="20%">
		&nbsp;</td>
		<td valign="top" width="21%">
		&nbsp;</td>
	</tr>
    <tr>
		<td valign="top" colspan="5"><font size="2">&nbsp; <u>beenmerg</u></font></td>
	</tr>
    <tr>
		<td valign="top">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_332_5.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_332_5_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_332_5.jpg"></a></td>
		<td valign="top" width="22%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_332_1.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_332_1_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_332_1.jpg"></a></td>
		<td valign="top" width="21%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_332_2.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_332_2_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_332_2.jpg"></a></td>
		<td valign="top" width="20%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_332_3.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_332_3_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_332_3.jpg"></a></td>
		<td valign="top" width="21%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_332_4.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_332_4_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_332_4.jpg"></a></td>
	</tr>
    <tr>
		<td valign="top">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_332_6.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_332_6_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_332_6.jpg"></a></td>
		<td valign="top" width="22%">
		&nbsp;</td>
		<td valign="top" width="21%">
		&nbsp;</td>
		<td valign="top" width="20%">
		&nbsp;</td>
		<td valign="top" width="21%">
		&nbsp;</td>
	</tr>
    <tr>
		<td valign="top">
		<font size="2">informatie 2</font></td>
		<td valign="top" colspan="4">
		<p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <b>
        <span lang="NL-BE"><font size="2" face="Times New Roman">BM-03-1541 </font></span>
        </b></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- man, 72 jaar</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- voorgeschiedenis: 
        prostaatadenocarcinoom </font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- consultatie omwille van 
        leukopenie</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- Hb 15.2 g/dl; WBC 1.2 10x9/l; 
        Blpl 132000</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="NL-BE"><font size="2" face="Times New Roman">- morfologie: 
        AML M3 (FAB) en AML met t(15;17) (WHO) met 5.7% blasten in beenmerg en 
        22.7% aberrante promyelocyten!</font></span></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="fr"><font face="Times New Roman" size="2">- IF (blasten): 
        CD117+, CD13+, CD33+, MPO+ partieel</font></span></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="fr"><font face="Times New Roman" size="2">-cytogenetica:
        </font></span>
        <font size="2" face="Times New Roman">t(15;17)(q22;q12);(PML/RARa-fusiegen)</font></p></td>
	</tr>
    <tr>
		<td valign="top" width="13%">
		<p style="margin-top: 0; margin-bottom: 0"><font size="2" face="Times New Roman">
		illustratie</font></td>
		<td valign="top" colspan="4">
		&nbsp;</td>
	</tr>
    <tr>
		<td valign="top" colspan="5"><font size="2">&nbsp; <u>perifeer bloed</u></font></td>
	</tr>
    <tr>
		<td valign="top">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_1541_1.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_1541_1_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_1541_1.jpg"></a></td>
		<td valign="top" width="22%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_1541_2.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_1541_2_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_1541_2.jpg"></a></td>
		<td valign="top" width="21%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_1541_3.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_1541_3_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_1541_3.jpg"></a></td>
		<td valign="top" width="20%">
		&nbsp;</td>
		<td valign="top" width="21%">
		&nbsp;</td>
	</tr>
    <tr>
		<td valign="top" colspan="5"><font size="2">&nbsp; <u>beenmerg</u></font></td>
	</tr>
	<tr>
		<td valign="top">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1541_9.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1541_9_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1541_9.jpg"></a></td>
		<td valign="top" width="22%">
		<p style="margin-top: 0; margin-bottom: 0">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1541_1.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1541_1_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1541_1.jpg"></a></td>
		<td valign="top" width="21%">
		<p style="margin-top: 0; margin-bottom: 0">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1541_2.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1541_2_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1541_2.jpg"></a></td>
		<td valign="top" width="20%">
		<p style="margin-top: 0; margin-bottom: 0">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1541_3.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1541_3_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1541_3.jpg"></a></td>
		<td valign="top" width="21%">
		<p style="margin-top: 0; margin-bottom: 0">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1541_4.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1541_4_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1541_4.jpg"></a></td>
	</tr>
    <tr>
		<td valign="top">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1541_5.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1541_5_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1541_5.jpg"></a></td>
		<td valign="top" width="22%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1541_6.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1541_6_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1541_6.jpg"></a></td>
		<td valign="top" width="21%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1541_7.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1541_7_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1541_7.jpg"></a></td>
		<td valign="top" width="20%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1541_8.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1541_8_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_1541_8.jpg"></a></td>
		<td valign="top" width="21%">
		&nbsp;</td>
	</tr>
	<tr>
		<td valign="top" colspan="5">
		<p align="center">
		<font face="Times New Roman">
		<b>
		<a target="_self" href="acute_myeloide_leukemie.htm">terug</a></b></font></td>
	</tr>
	<tr>
		<td valign="top" colspan="5">
		<p><a name="aml4"></a></p>
		<hr color="#405890" size="1">
        </td>
	</tr>
	<tr>
		<td valign="top" colspan="5">
		<p class="MsoNormal"><font face="Times New Roman"><b>Acute myeloïde leukemie met 11q23 (MLL) 
        afwijkingen</b></font></td>
	</tr>
	<tr>
		<td valign="top">
		<p style="margin-top: 0; margin-bottom: 0">
        <font size="2" face="Times New Roman">beschrijving</font></td>
		<td valign="top" colspan="4">
		<p style="margin-top: 0; margin-bottom: 0">
        <font size="2" face="Times New Roman">- vaak 
        monocytaire kenmerken</font></p>
        <p style="margin-top: 0; margin-bottom: 0">
        <font size="2" face="Times New Roman">- 5 - 6% van 
        AML - patiënten</font></p>
        <p style="margin-top: 0; margin-bottom: 0">
        <font size="2" face="Times New Roman">- alle 
        leeftijden, vooral bij kinderen en na behandeling met DNA Topoisomerase 
        II inhibitoren</font></td>
	</tr>
	<tr>
		<td valign="top">
		<p style="margin-top: 0; margin-bottom: 0"><font size="2" face="Times New Roman">
		kliniek</font></td>
		<td valign="top" colspan="4">
		<p style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- cfr. kliniek AML</font></p>
        <p style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- soms presentatie met 
        extramedullaire monocytaire sarcomen en/of weefsel infiltratie, DIC kan 
        voorkomen</font></td>
	</tr>
	<tr>
		<td valign="top">
		<p style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">cytologie</font></td>
		<td valign="top" colspan="4">
		<p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- anemie, trombopenie, 
        leukocytose (vaak circulerende blasten)</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- komt voor bij acute monoblasten/monocyten 
        leukemie en myelomonocytaire leukemie, maar hoofdzakelijk bij 
        monoblasten leukemie met typisch predominantie van monoblasten en 
        promonocyten</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- monoblasten: basofiel 
        cytoplasma, ronde kern, fijnmazig kernchromatine, enkele nucleoli</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- promonocyten: lichter blauw cytoplasma, boonvormige kern</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">-&nbsp; vaak sterke NSE-reactie, 
        monoblasten vaak MPO - negatief</font></td>
	</tr>
	<tr>
		<td valign="top">
		<p style="margin-top: 0; margin-bottom: 0"><font size="2" face="Times New Roman">
		andere</font></td>
		<td valign="top" colspan="4">
		<p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">1.Immunofenotypering</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">&nbsp; - positieve myeloïde 
        merkers (CD13,CD33). </font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">&nbsp; - vaak negatief voor CD34 met variabele expressie van 
        monocytaire merkers (CD4, CD14, CD11b,CD11c,CD64..)</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">2. Cytogenetica / moleculaire 
        diagnostiek</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">&nbsp; - 11q23 (MLL-gen)</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">3.Prognose</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">&nbsp; - intermediaire prognose</font></td>
	</tr>
	<tr>
		<td valign="top">
		<font size="2">informatie 1</font></td>
		<td valign="top" colspan="4">
		<p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <b>
        <span lang="NL-BE"><font size="2" face="Times New Roman">BM-05-920 </font></span>
        </b></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- vrouw, 56 jaar</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- voorgeschiedenis: borstcarcinoom
        </font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- kliniek: ecchymosen en 
        petechieën, nachtzweten, hoofdpijn en duizeligheid sedert enkele dagen</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- Hb 11.2 g/dl; WBC 162.3 10x9/l; 
        Blpl 56000</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="NL-BE"><font size="2" face="Times New Roman">- morfologie: 
        AML M5a (FAB) en AML met 11q23 afwijking (WHO) met 92.7% blasten in 
        beenmerg</font></span></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="fr"><font face="Times New Roman" size="2">- IF (blasten): 
        CD13 sterk, CD33+, MPO+, CD11b+, HLA-Dr sterk, CD15+, CD4+, CD56+</font></span></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="fr"><font face="Times New Roman" size="2">-cytogenetica:
        </font></span>
        <font face="Times New Roman" size="2">11q23 (MLL-gen) afwijking</font></p></td>
	</tr>
    <tr>
		<td valign="top" width="13%">
		<p style="margin-top: 0; margin-bottom: 0"><font size="2" face="Times New Roman">
		illustratie</font></td>
		<td valign="top" colspan="4">
		&nbsp;</td>
	</tr>
    <tr>
		<td valign="top" colspan="5"><font size="2">&nbsp; <u>perifeer bloed</u></font></td>
	</tr>
    <tr>
		<td valign="top">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_920_4.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_920_4_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_920_4.jpg"></a></td>
		<td valign="top" width="22%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_920_1.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_920_1_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_920_1.jpg"></a></td>
		<td valign="top" width="21%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_920_2.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_920_2_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_920_2.jpg"></a></td>
		<td valign="top" width="20%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_920_3.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_920_3_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_920_3.jpg"></a></td>
		<td valign="top" width="21%">
		&nbsp;</td>
	</tr>
    <tr>
		<td valign="top" colspan="5"><font size="2">&nbsp; <u>beenmerg</u></font></td>
	</tr>
    <tr>
		<td valign="top">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_920_1.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_920_1_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_920_1.jpg"></a></td>
		<td valign="top" width="22%">
		<p style="margin-top: 0; margin-bottom: 0">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_920_2.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_920_2_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_920_2.jpg"></a></td>
		<td valign="top" width="21%">
		<p style="margin-top: 0; margin-bottom: 0">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_920_3.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_920_3_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_920_3.jpg"></a></td>
		<td valign="top" width="20%">
		<p style="margin-top: 0; margin-bottom: 0">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_920_4.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_920_4_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_920_4.jpg"></a></td>
		<td valign="top" width="21%">
		<p style="margin-top: 0; margin-bottom: 0">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_920_5.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_920_5_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_920_5.jpg"></a></td>
	</tr>
    <tr>
		<td valign="top">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_920_6.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_920_6_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_920_6.jpg"></a></td>
		<td valign="top" width="22%">
		&nbsp;</td>
		<td valign="top" width="21%">
		&nbsp;</td>
		<td valign="top" width="20%">
		&nbsp;</td>
		<td valign="top" width="21%">
		&nbsp;</td>
	</tr>
    <tr>
		<td valign="top" colspan="5"><font size="2">&nbsp; <u>andere kleuringen</u></font></td>
	</tr>
    <tr>
		<td valign="top">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/kl_920_1.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/kl_920_1_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/kl_920_1.jpg"></a></td>
		<td valign="top" width="22%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/kl_920_2.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/kl_920_2_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/kl_920_2.jpg"></a></td>
		<td valign="top" width="21%">
		&nbsp;</td>
		<td valign="top" width="20%">
		&nbsp;</td>
		<td valign="top" width="21%">
		&nbsp;</td>
	</tr>
    <tr>
		<td valign="top">
		<font size="2">informatie 2</font></td>
		<td valign="top" colspan="4">
		<p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <b>
        <span lang="NL-BE"><font size="2" face="Times New Roman">BM-05-817 </font></span>
        </b></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- vrouw, 37 jaar</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- kliniek: moe, dyspnee gr. II en 
        palpitaties sedert enkele weken</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2">- Hb 6.2 g/dl; WBC 2.1 10x9/l; 
        Blpl 166000</font></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="NL-BE"><font size="2" face="Times New Roman">- morfologie: 
        AML M5a (FAB) en AML met 11q23 afwijking (WHO) met 93.2% blasten in 
        beenmerg</font></span></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <span lang="fr"><font face="Times New Roman" size="2">- IF (blasten): 
        CD117+, CD33+, CD11b heterogeen, HLA-Dr heterogeen tot sterk, CD15+, 
        CD4+, CD56 partieel</font></span></p>
        <p class="MsoNormal" style="margin-top: 0; margin-bottom: 0">
        <font face="Times New Roman" size="2"><span lang="fr">-cytogenetica:
        </span>11q23 (MLL-gen) afwijking</font></p></td>
	</tr>
    <tr>
		<td valign="top" width="13%">
		<p style="margin-top: 0; margin-bottom: 0"><font size="2" face="Times New Roman">
		illustratie</font></td>
		<td valign="top" colspan="4">
		&nbsp;</td>
	</tr>
    <tr>
		<td valign="top" colspan="5"><font size="2">&nbsp; <u>perifeer bloed</u></font></td>
	</tr>
    <tr>
		<td valign="top">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_817_1.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_817_1_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_817_1.jpg"></a></td>
		<td valign="top" width="22%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_817_2.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_817_2_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_817_2.jpg"></a></td>
		<td valign="top" width="21%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_817_3.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_817_3_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/pb_817_3.jpg"></a></td>
		<td valign="top" width="20%">
		&nbsp;</td>
		<td valign="top" width="21%">
		&nbsp;</td>
	</tr>
    <tr>
		<td valign="top" colspan="5"><font size="2">&nbsp; </font><u>
		<font size="2">beenmerg</font></u></td>
	</tr>
    <tr>
		<td valign="top">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_817_1.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_817_1_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_817_1.jpg"></a></td>
		<td valign="top" width="22%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_817_2.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_817_2_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_817_2.jpg"></a></td>
		<td valign="top" width="21%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_817_3.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_817_3_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_817_3.jpg"></a></td>
		<td valign="top" width="20%">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_817_4.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_817_4_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/bm_817_4.jpg"></a></td>
		<td valign="top" width="21%">
		&nbsp;</td>
	</tr>
    <tr>
		<td valign="top" colspan="5"><font size="2">&nbsp; <u>andere kleuringen</u></font></td>
	</tr>
    <tr>
		<td valign="top">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/kl_817_2.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/kl_817_2_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/kl_817_2.jpg"></a></td>
		<td valign="top" width="22%">
		<p style="margin-top: 0; margin-bottom: 0">
		<a href="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/kl_817_1.jpg">
		<img border="1" src="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/kl_817_1_small.jpg" xthumbnail-orig-image="../../../images/ziekten/hemato_mal/aml/1_kar_cyto/kl_817_1.jpg"></a></td>
		<td valign="top" width="21%">
		<p style="margin-top: 0; margin-bottom: 0">&nbsp;</td>
		<td valign="top" width="20%">
		<p style="margin-top: 0; margin-bottom: 0">&nbsp;</td>
		<td valign="top" width="21%">
		<p style="margin-top: 0; margin-bottom: 0">&nbsp;</td>
	</tr>
	<tr>
		<td valign="top" colspan="5">
		<p align="center">
		<font face="Times New Roman">
		<b>
		<a target="_self" href="acute_myeloide_leukemie.htm">terug</a></b></font></td>
	</tr>
	<tr>
		<td valign="top" colspan="5">
		<hr color="#405890" size="1">
        </td>
	</tr>
</table>

</body>

</html>